Benzimidazole - CAS 51-17-2
Catalog: |
BB027355 |
Product Name: |
Benzimidazole |
CAS: |
51-17-2 |
Synonyms: |
1H-benzimidazole; 1H-benzimidazole |
IUPAC Name: | 1H-benzimidazole |
Description: | Benzimidazole (CAS# 51-17-2) is used as a reagent in the synthesis of Chalcone (C291855) derivatives which can exhibit antiplasmodial activity. Benzimidazole is also a reagent in the synthesis of quinazolines and quinazolinones which can be used as anti-inflammatory agents and PDE4B inhibitors. |
Molecular Weight: | 118.14 |
Molecular Formula: | C7H6N2 |
Canonical SMILES: | C1=CC=C2C(=C1)NC=N2 |
InChI: | InChI=1S/C7H6N2/c1-2-4-7-6(3-1)8-5-9-7/h1-5H,(H,8,9) |
InChI Key: | HYZJCKYKOHLVJF-UHFFFAOYSA-N |
Boiling Point: | 360 °C |
Melting Point: | 338 to 342 °F |
Purity: | 98.0% |
Density: | 1.242 g/cm3 |
Solubility: | >17.7 [ug/mL] (The mean of the results at pH 7.4) |
Appearance: | Rhombic, Bipyramidal plates in water |
Decomposition: | Dangerous; when heated to decomposition, It emits highly toxic fumes |
MDL: | MFCD00005585 |
LogP: | 1.56290 |
pH: | Weak base |
Stability: | High degree of chemical stability |
Vapor Pressure: | 0.0000764 [mmHg] |
GHS Hazard Statement: | H302 (95.88%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P264, P270, P301+P312, P330, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-2021147442-A1 | Organic compound, electroluminescent material, and application thereof | 20201030 |
US-2021104678-A1 | Organic compound, electroluminescent material, and use thereof | 20200922 |
US-10975102-B1 | Heterocyclic diazenyl pyridinone copper(II) complexes as pharmacological antitumor agents | 20200921 |
US-11028300-B1 | Environmentally friendly refrigerant compositions | 20200916 |
EP-3842452-A1 | Scaffold proteins and therapeutic nanoconjugates based on nidogen | 20191226 |
PMID | Publication Date | Title | Journal |
33930522 | 20210901 | Benomyl induced oxidative stress related DNA damage and apoptosis in H9c2 cardiomyoblast cells | Toxicology in vitro : an international journal published in association with BIBRA |
32446185 | 20200801 | Assessing the toxicity of the benzamide fungicide zoxamide in zebrafish (Danio rerio): Towards an adverse outcome pathway for beta-tubulin inhibitors | Environmental toxicology and pharmacology |
32258933 | 20200330 | Lerisetron Analogues with Antimalarial Properties: Synthesis, Structure-Activity Relationship Studies, and Biological Assessment | ACS omega |
30433781 | 20181213 | Discovery of Clinical Candidate 2-(4-(2-((1 H-Benzo[ d]imidazol-2-yl)thio)ethyl)piperazin-1-yl)- N-(6-methyl-2,4-bis(methylthio)pyridin-3-yl)acetamide Hydrochloride [K-604], an Aqueous-Soluble Acyl-CoA:Cholesterol O-Acyltransferase-1 Inhibitor | Journal of medicinal chemistry |
30496565 | 20181201 | Insights into a Possible Mechanism Underlying the Connection of Carbendazim-Induced Lipid Metabolism Disorder and Gut Microbiota Dysbiosis in Mice | Toxicological sciences : an official journal of the Society of Toxicology |
Complexity: | 103 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 118.053098200 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 118.053098200 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 28.7 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Benzimidazoles
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS